Schedule 13G ownership disclosure
Coya Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 22407B108
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Orin Hirschman
Shares: 1,108,171.00 · Class: 5.3%
- AIGH Capital Management LLC
Shares: 975,404.00 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-003978
- Form type
- SCHEDULE 13G/A
- Filer
- Coya Therapeutics, Inc.
- CIK
- CIK 1835022
- Filed
- Jan 28, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership